In reply to duchessofmalfi:
I’m on the fence.
One interpretation of 2.c and 2.d is that you don’t need BCG to have low deaths, but that it’s a nice emergency backup to having a government totally jump the shark in their response...
Really there’s not enough data there to be conclusive about the benefits, but also there’s no data in the paper to demolish the hypothesis. It’s hard to see how data at the national level could ever give high quality support. Longitudinal studies might but that’ll be an awful lot of work. Histology studies of ACE va ACE2 in the dead would be more conclusive I should think. I doubt suitable samples have routinely been harvested before burial/cremation?
Post edited at 09:41